hims retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide (Research Use) | Aion

doi: 10.1016/j.neuron.2011.12.033 212 ZengL

Companies get in trouble when a customer could reasonably confuse their product for the real thing, and that holds true far beyond GLP-1s

Side Effects and How They Are Managed Common side effects of Contrave include nausea, constipation, headache, dry mouth, or difficulty sleeping

Eligibility is determined by CMS and requires a healthcare provider to certify that a beneficiary meets the medical criteria

Project results Nguyen and colleagues collected data on obesity drug prescriptions through electronic health records and pharmacy dispensing systems from January 2022 up to May 2025